YI logo

111, Inc. Stock Price

NasdaqGM:YI Community·US$39.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

YI Share Price Performance

US$4.50
-7.40 (-62.19%)
US$4.50
-7.40 (-62.19%)
Price US$4.50

YI Community Narratives

There are no narratives available yet.

Recent YI News & Updates

It's Down 32% But 111, Inc. (NASDAQ:YI) Could Be Riskier Than It Looks

Jan 25
It's Down 32% But 111, Inc. (NASDAQ:YI) Could Be Riskier Than It Looks

A Look At The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

Sep 10
A Look At The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

111, Inc. Key Details

CN¥14.2b

Revenue

CN¥13.8b

Cost of Revenue

CN¥405.4m

Gross Profit

CN¥479.5m

Other Expenses

-CN¥74.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-8.55
Gross Margin
2.86%
Net Profit Margin
-0.52%
Debt/Equity Ratio
52.6%

111, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet and good value.

1 Risk
2 Rewards

About YI

Founded
2010
Employees
1238
CEO
Junling Liu
WebsiteView website
corporate.111.com.cn

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides pharmaceutical products and other merchandise. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies’ historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.3%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
Over the past 7 days, the market has risen 1.8% with the Industrials sector contributing the most to the gain. In the last year, the market has climbed 24%. Looking forward, earnings are forecast to grow by 27% annually. Market details ›